Aarti Drugs on expansion spree; consider Rs 400 million capital expenditure

Aarti Drugs on expansion spree; consider Rs 400 million capital expenditure
Aarti Drugs is on expansion spree; the company announced that it is considering proposal for capital expenditure (capex) aggregating up to Rs 400 million by way of expansion / acquisition.

This capital expenditure is to be funded by external commercial borrowing (ECB).

Aarti Drugs is a pharmaceutical company, manufactures and sells bulk drugs and specialty chemicals worldwide. The company focuses on the anti-diarrhea, anti-inflammatory therapeutic groups.

Disclaimer: Information presented on this site is a guide only. It may not necessarily be correct and is not intended to be taken as financial advice nor has it been prepared with regard to the individual investment needs and objectives or financial situation of any particular person. Stock quotes are believed to be accurate and correctly dated, but does not warrant or guarantee their accuracy or date.
Our site takes no responsibility for any investment decisions based on recommendations provided on website.